Search research articles
Contact Us
Filters
Showing results (81-90 of 159) with videos related to
Page
of 16
Sort By:
Cancer Research Communications
|
April 19, 2024
Synergy of EGFR and AURKA Inhibitors in KRAS-mutated Non-small Cell Lung Cancers
Tetyana Bagnyukova, Brian L Egleston, Valerii A Pavlov, et al.
Expert Opinion on Therapeutic Targets
|
February 25, 2009
Mechanisms of tumor resistance to EGFR-targeted therapies
Elizabeth A Hopper-Borge, Rochelle E Nasto, Vladimir Ratushny, et al.
Cancer Research
|
October 14, 2010
Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9
Mahendra K Singh, Eugene Izumchenko, Andres J Klein-Szanto, et al.
Plos One
|
June 16, 2012
The centrosomal kinase Plk1 localizes to the transition zone of primary cilia and induces phosphorylation of nephrocystin-1
Tamina Seeger-Nukpezah, Max C Liebau, Katja Höpker, et al.
Cell Division
|
September 10, 2010
The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation
Finola E Moore, Evan C Osmundson, Jennifer Koblinski, et al.
Plos One
|
April 29, 2017
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model
Alexander Y Deneka, Leora Haber, Meghan C Kopp, et al.
Molecular & Cellular Proteomics : MCP
|
March 23, 2005
A combined yeast/bacteria two-hybrid system: development and evaluation
Ilya G Serebriiskii, Rui Fang, Ekaterina Latypova, et al.
Cancer Biology & Therapy
|
October 12, 2010
Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?
Tetyana V Bagnyukova, Ilya G Serebriiskii, Yan Zhou, et al.
Genes & Development
|
June 28, 2018
Molecular mechanisms of the preventable causes of cancer in the United States
Erica A Golemis, Paul Scheet, Tim N Beck, et al.
Molecular Biology of the Cell
|
May 25, 2012
Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis
Olga V Plotnikova, Anna S Nikonova, Yuri V Loskutov, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 159) with videos related to
Sort By:
Page
of 16
Cancer Research Communications
|
April 19, 2024
Synergy of EGFR and AURKA Inhibitors in KRAS-mutated Non-small Cell Lung Cancers
Tetyana Bagnyukova, Brian L Egleston, Valerii A Pavlov, et al.
Expert Opinion on Therapeutic Targets
|
February 25, 2009
Mechanisms of tumor resistance to EGFR-targeted therapies
Elizabeth A Hopper-Borge, Rochelle E Nasto, Vladimir Ratushny, et al.
Cancer Research
|
October 14, 2010
Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9
Mahendra K Singh, Eugene Izumchenko, Andres J Klein-Szanto, et al.
Plos One
|
June 16, 2012
The centrosomal kinase Plk1 localizes to the transition zone of primary cilia and induces phosphorylation of nephrocystin-1
Tamina Seeger-Nukpezah, Max C Liebau, Katja Höpker, et al.
Cell Division
|
September 10, 2010
The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation
Finola E Moore, Evan C Osmundson, Jennifer Koblinski, et al.
Plos One
|
April 29, 2017
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model
Alexander Y Deneka, Leora Haber, Meghan C Kopp, et al.
Molecular & Cellular Proteomics : MCP
|
March 23, 2005
A combined yeast/bacteria two-hybrid system: development and evaluation
Ilya G Serebriiskii, Rui Fang, Ekaterina Latypova, et al.
Cancer Biology & Therapy
|
October 12, 2010
Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?
Tetyana V Bagnyukova, Ilya G Serebriiskii, Yan Zhou, et al.
Genes & Development
|
June 28, 2018
Molecular mechanisms of the preventable causes of cancer in the United States
Erica A Golemis, Paul Scheet, Tim N Beck, et al.
Molecular Biology of the Cell
|
May 25, 2012
Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis
Olga V Plotnikova, Anna S Nikonova, Yuri V Loskutov, et al.
Page
of 16